Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
IL5 VHH recombinant monoclonal antibody
IL5RA VHH recombinant monoclonal antibody
IL6 VHH recombinant monoclonal antibody
IL6R VHH recombinant monoclonal antibody
IL7R VHH recombinant monoclonal antibody
IL9 VHH recombinant monoclonal antibody
ILDR2 VHH recombinant monoclonal antibody
INHBA VHH recombinant monoclonal antibody
INSR VHH recombinant monoclonal antibody
Integrin α5β1 VHH recombinant monoclonal antibody
ITGA2 VHH recombinant monoclonal antibody
ITGA4 VHH recombinant monoclonal antibody